Winslow Evans & Crocker’s Prothena Corp PRTA Stock Holding History

Winslow Evans & Crocker’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1K	Buy	+100	New	+$1.18K	﹤0.01%	1289
2018 Q4	–	Sell	-200	Closed	-$4K	–	1124
2018 Q3	$4K	Hold	200	–	–	﹤0.01%	967
2018 Q2	$4K	Sell	200 -10	-5%	-$198	﹤0.01%	976
2018 Q1	$7.71K	Hold	210	–	–	﹤0.01%	839
2017 Q4	$7.87K	Sell	210 -290	-58%	-$14.8K	﹤0.01%	852
2017 Q3	$32.4K	Sell	500 -510	-50%	-$31.2K	0.01%	561
2017 Q2	$55.2K	Buy	1,010 +600	+146%	+$32K	0.02%	539
2017 Q1	$22.9K	Hold	410	–	–	0.01%	703
2016 Q4	$20.2K	Sell	410 -300	-42%	-$16.6K	0.01%	721
2016 Q3	$42.6K	Hold	710	–	–	0.01%	578
2016 Q2	$24.8K	Hold	710	–	–	0.01%	653
2016 Q1	$29.2K	Hold	710	–	–	0.01%	615
2015 Q4	$48.4K	Sell	710 -40	-5%	-$2.41K	0.01%	540
2015 Q3	$34K	Hold	750	–	–	0.01%	579
2015 Q2	$39.5K	Hold	750	–	–	0.01%	599
2015 Q1	$28.6K	Hold	750	–	–	0.01%	657
2014 Q4	$15.6K	Hold	750	–	–	﹤0.01%	794
2014 Q3	$16.6K	Buy	+750	New	+$15.9K	﹤0.01%	780

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Winslow Evans & Crocker's PRTA Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Prothena Corp (PRTA) in Q4 2020: 100 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1289 among its holdings. This is a return to the name: Winslow Evans & Crocker previously reported a position in PRTA as recently as Q3 2018.

Winslow Evans & Crocker first reported a position in PRTA in Q3 2014 and has held it in 18 quarters since. The position peaked at $55.2K in Q2 2017. 140 funds tracked by Wall St. Rank hold PRTA as of Q4 2020.

Winslow Evans & Crocker held 100 shares of Prothena Corp worth $1K as of Q4 2020.
Prothena Corp was a new Winslow Evans & Crocker position in Q4 2020.
Prothena Corp made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1289 holding.
Winslow Evans & Crocker first reported a position in Prothena Corp in Q3 2014 and has held it in 18 quarters since.
Winslow Evans & Crocker's Prothena Corp position peaked at $55.2K in Q2 2017.
140 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.